NDA 9667, held by Valeant Pharm Intl. Reserpine.
As of Nov 14, 2026, NDA 9667 (Reserpine), held by Valeant Pharm Intl, was not approved, with 3 approved supplements and 0 published complete response letters.
| Oct 18, 1979 | Supplement 18Labeling | Approved | None posted |
| Sep 12, 1979 | Supplement 16Manufacturing · Standard review | Approved | None posted |
| Dec 7, 1976 | Supplement 15Labeling | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
